[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Ahmad, 2005 - Google Patents

The vertical transmission of human immunodeficiency virus type 1: molecular and biological properties of the virus

Ahmad, 2005

Document ID
14813171447690374067
Author
Ahmad N
Publication year
Publication venue
Critical Reviews in Clinical Laboratory Sciences

External Links

Snippet

The vertical (mother-to-infant) transmission of human immunodeficiency virus type 1 (HIV-1) occurs at an estimated rate of more than 30% and is the major cause of AIDS in children. Numerous maternal parameters, including advanced clinical stages, low CD4+ lymphocyte …
Continue reading at www.tandfonline.com (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988AIDS or HTLV
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse Transcribing RNA Viruses
    • C12N2740/00011Reverse Transcribing RNA Viruses
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/21Retroviridae, e.g. equine infectious anemia virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
    • C12Q1/701Specific hybridization probes

Similar Documents

Publication Publication Date Title
Ahmad The vertical transmission of human immunodeficiency virus type 1: molecular and biological properties of the virus
Levy The retroviridae
Lawn et al. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection
Ometto et al. Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission
Mofenson Interaction between timing of perinatal human immunodeficiency virus infection and the design of preventive and therapeutic interventions
Haigwood et al. Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile
Miyazawa et al. The ‘immunologic advantage’of HIV-exposed seronegative individuals
Hirsch et al. A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3
Ahmad Molecular mechanisms of HIV-1 mother-to-child transmission and infection in neonatal target cells
Schwartz et al. Current concepts in human immunodeficiency virus infection and AIDS
D'SOUZA et al. Meeting Report: Early Phases of HIV Type 1 Infection1, 2, 3
Ahmad Maternal-fetal transmission of human immunodeficiency virus
Allison et al. Feline immunodeficiency virus is concentrated in milk early in lactation
Schreiber et al. Antibodies of symptomatic human immunodeficiency virus type 1-infected individuals are directed to the V3 domain of noninfectious and not of infectious virions present in autologous serum
Johnson et al. Cellular immune responses to HIV-1
Farquhar et al. The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression
Kolenda-Roberts et al. Immunopathogenesis of feline immunodeficiency virus infection in the fetal and neonatal cat
Guatelli et al. Human immunodeficiency virus
Weiss et al. Human immunodeficiency viruses
Rossi et al. Mother‐to‐child transmission of human immunodeficiency virus
Azevedo-Pereira HIV-2 interaction with target cell receptors, or why HIV-2 is less pathogenic than HIV-1
Koning et al. Biological and molecular aspects of HIV-1 coreceptor usage
Chen et al. Dependence of CD8+ T-cell-mediated suppression of HIV type 1 on viral phenotypes and mediation of phenotype-dependent suppression by viral envelope gene and not by beta-chemokines
Hosie et al. Feline Immunodeficiency Virus
Rocha Analysis of antibody neutralization specificities in Human Immunodeficiency Virus Type 2 infection